FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to medicine and pharmacy and aims at inhibiting dimerisation of IL-6 receptor antibodies in a liquid composition. Method for inhibiting dimerisation of IL-6 receptor antibody molecules in a liquid composition containing said antibody in a concentration of at least 120 mg/ml involves adding arginine and methionine to the liquid composition.
EFFECT: use of the invention provides effective inhibition of IL-6 receptor antibody dimerisation in a liquid composition.
9 cl, 8 dwg, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIQUID COMPOSITION CONTAINING HIGH CONCENTRATION ANTIBODY | 2008 |
|
RU2497544C2 |
| LIQUID COMPOSITION CONTAINING HIGH CONCENTRATION ANTIBODY | 2019 |
|
RU2795116C2 |
| PHARMACEUTICAL FORMULATION CONTAINING ADVANCED ANTIBODY MOLECULES | 2010 |
|
RU2565809C2 |
| HUMANIZED ANTI-EPIREGULIN-ANTIBODY AND ANTI-TUMOUR THERAPEUTIC AGENT CONTAINING THIS ANTIBODY AS ACTIVE INGREDIENT | 2012 |
|
RU2634383C2 |
| SOLUTION PREPARATION CONTAINING STABILIZED ANTIBODIES | 2011 |
|
RU2653447C2 |
| METHOD OF MODIFICATION OF POLYPEPTIDE FOR PURIFICATION OF POLYPEPTIDE MULTIMERS | 2010 |
|
RU2606264C2 |
| STABLE LIQUID PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2773747C2 |
| COMPOSITIONS OF ANTIBODIES | 2005 |
|
RU2426554C2 |
| THERAPY OF MALIGNANT TUMOR, RESISTANT TO PLATINUM-BASED MEDICATIONS | 2005 |
|
RU2403065C2 |
| NEW ANTI-DR5 ANTIBODY | 2011 |
|
RU2644678C1 |
